This is a routine procedural dismissal of an individual pro se consumer complaint against Equifax, no financial exposure, no market impact. The stock has no material legal catalyst from this ruling.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 3 $170.16entry
- T+1 · 6mo ago +0.49%α +0.11% · $170.99
- T+5 · 5mo ago −2.41%α +1.41% · $166.06
- T+20 · 5mo ago +1.12%α +2.38% · $172.07
- T+60 · 3mo ago +14.22%α +12.21% · $194.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A pro se plaintiff's FCRA, FDCPA, and negligence claims against Equifax Information Services, LLC were dismissed by the District of Delaware at the screening stage for failure to state a claim. The FCRA and negligence counts were dismissed without prejudice with leave to amend; the FDCPA claims were dismissed with prejudice because Equifax is not a 'debt collector' under the statute. This is a routine individual consumer credit report dispute with zero financial exposure or precedent risk for Equifax.
Court Ruling Details
Key Facts
- Plaintiff Jream David Boyer sued Equifax Information Services, LLC pro se under FCRA, FDCPA, and state negligence.
- The court dismissed all claims on screening under 28 U.S.C. § 1915(e)(2)(B) for failure to state a claim.
- FCRA counts (I-III) and negligence count (VI) were dismissed without prejudice with leave to amend.
- FDCPA counts (IV & V) were dismissed with prejudice because Equifax is not a debt collector under the statute.
- No damages were awarded, no injunction was issued, and no financial exposure to Equifax was quantified in the ruling.
- The ruling is a routine procedural screening dismissal of an individual pro se complaint.
Financial Impact
None. The complaint was dismissed at the screening stage with zero damages awarded, no financial exposure stated, and no injunction imposed.
Risk Factors
- Plaintiff may file an amended complaint on the FCRA and negligence counts, but the bar for a pro se litigant to plead specific inaccuracies is high and material exposure is near zero.
- No broader legal or regulatory risk to Equifax from this individual case.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-2vb76xvl-EFX |
Track record
81 reports on EFX
7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +18.79% at T+60 after the May 27, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $188.12 to $189.50 Now $189.50 +0.73% ▲ +0.73% +2.65% vs SPY
- Nov 12, 20265d ago Court Ruling Neutral 1/10 Entry $188.12 to $189.50 Now $189.50 +0.73% ▲ +0.73% +2.65% vs SPY
- Nov 12, 20265d ago Court Ruling Neutral 1/10 Entry $188.12 to $189.50 Now $189.50 +0.73% ▲ +0.73% +2.65% vs SPY
- Nov 12, 20265d ago Court Ruling Neutral 2/10 Entry $188.12 to $189.50 Now $189.50 +0.73% ▲ +0.73% +2.65% vs SPY
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $188.33 to $188.23 Now $189.50 +0.62% ▼ −0.05% +0.31% vs SPY
- Nov 6, 202611d ago Court Ruling Neutral 1/10 Entry $188.33 to $188.23 Now $189.50 +0.62% ▼ −0.05% +0.31% vs SPY
- Nov 5, 202611d ago Press Release Neutral 2/10 Entry $193.84 to $189.59 Now $189.50 −2.24% ▼ −2.19% −2.50% vs SPY
- Nov 5, 202612d ago Court Ruling Neutral 1/10 Entry $189.59 to $188.33 Now $189.50 −0.05% ▼ −0.66% −3.03% vs SPY
- Nov 4, 202613d ago Court Ruling Neutral 1/10 Entry $193.84 to $189.59 Now $189.50 −2.24% ▼ −2.19% −2.50% vs SPY
- Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $187.72 to $192.21 Now $189.50 +0.95% ▲ +2.39% +0.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers